Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02029846 · ClinicalTrials.gov registry record · Phase 4
Glycemia in Diabetic Elders Trial
A Phase 4 study, sponsored by Johns Hopkins University.
- Terminated
- Registry status
- Phase 4
- Development phase
- 2
- Enrollment target
NCT02029846: Clinical Trial Phase 4 study, sponsored by Johns Hopkins University.
NCT02029846 is a Phase 4 study that was terminated before completion, run by Johns Hopkins University. The registered enrollment target is 2 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02029846, a Phase 4 study, was terminated before completion, sponsored by Johns Hopkins University.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 2 participants
- Enrollment target
Study Summary
This study is a pilot randomized controlled trial of 30 elderly type 2 diabetes patients conducted at the MODEL Clinical Research (MODEL), Research Division of Bay West Endocrinology Associates in Baltimore, Maryland. The investigators hypothesized that compared to a regimen base solely on traditional drugs, a regimen including newer drugs will achieve glycemic target faster and induce less hypoglycemia, weight gain, and other side effects, over the short run.
Interventions
- DRUG Standard Treatment
- DRUG Incretin-Based Treatment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2013-04 |
| Est. Completion | 2017-02 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02029846
The ClinicalTrials.gov registry entry for NCT02029846 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 2 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Standard Treatment is the first listed.
NCT02029846 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02029846 about?
NCT02029846 is a clinical study titled "Glycemia in Diabetic Elders Trial". This study is a pilot randomized controlled trial of 30 elderly type 2 diabetes patients conducted at the MODEL Clinical Research (MODEL), Research Division of Bay West Endocrinology Associates in Baltimore, Maryland. The investigators hypothesized that compared to a regimen base solely on tradition...
What is the current status of trial NCT02029846?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 2 participants. The study started on 2013-04. Estimated completion is 2017-02.
What interventions are being tested in trial NCT02029846?
The interventions under investigation include: Standard Treatment (DRUG), Incretin-Based Treatment (DRUG).
Who is sponsoring clinical trial NCT02029846?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.